Surface antibody changes protein corona both in human and mouse serum but not final opsonization and elimination of targeted polymeric nanoparticles
Nanoparticles represent one of the most important innovations in the medical field. Among nanocarriers, polymeric nanoparticles (PNPs) attracted much attention due to their biodegradability, biocompatibility, and capacity to increase efficacy and safety of encapsulated drugs. Another important impro...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
14 October 2023
|
| In: |
Journal of nanobiotechnology
Year: 2023, Volume: 21 |
| ISSN: | 1477-3155 |
| DOI: | 10.1186/s12951-023-02134-4 |
| Online Access: | Resolving-System, kostenfrei: https://dx.doi.org/10.1186/s12951-023-02134-4
|
| Author Notes: | Sara Capolla, Federico Colombo, Luca De Maso, Prisca Mauro, Paolo Bertoncin, Thilo Kähne, Alexander Engler, Luis Núñez, Ruben Spretz, Gustavo Larsen, Michele Dal Bo, Giuseppe Toffoli and Paolo Macor |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1869503732 | ||
| 003 | DE-627 | ||
| 005 | 20240307043125.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231107s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12951-023-02134-4 |2 doi | |
| 035 | |a (DE-627)1869503732 | ||
| 035 | |a (DE-599)KXP1869503732 | ||
| 035 | |a (OCoLC)1425209713 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 32 |2 sdnb | ||
| 100 | 1 | |a Capolla, Sara |e VerfasserIn |0 (DE-588)1316568865 |0 (DE-627)1878493205 |4 aut | |
| 245 | 1 | 0 | |a Surface antibody changes protein corona both in human and mouse serum but not final opsonization and elimination of targeted polymeric nanoparticles |c Sara Capolla, Federico Colombo, Luca De Maso, Prisca Mauro, Paolo Bertoncin, Thilo Kähne, Alexander Engler, Luis Núñez, Ruben Spretz, Gustavo Larsen, Michele Dal Bo, Giuseppe Toffoli and Paolo Macor |
| 264 | 1 | |c 14 October 2023 | |
| 300 | |b Illustrationen | ||
| 300 | |a 20 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 19.01.2024 | ||
| 520 | |a Nanoparticles represent one of the most important innovations in the medical field. Among nanocarriers, polymeric nanoparticles (PNPs) attracted much attention due to their biodegradability, biocompatibility, and capacity to increase efficacy and safety of encapsulated drugs. Another important improvement in the use of nanoparticles as delivery systems is the conjugation of a targeting agent that enables the nanoparticles to accumulate in a specific tissue. Despite these advantages, the clinical translation of therapeutic approaches based on nanoparticles is prevented by their interactions with blood proteins. In fact, the so-formed protein corona (PC) drastically alters the biological identity of the particles. Adsorbed activated proteins of the complement cascade play a pivotal role in the clearance of nanoparticles, making them more easily recognized by macrophages, leading to their rapid elimination from the bloodstream and limiting their efficacy. Since the mouse is the most used preclinical model for human disease, this work compared human and mouse PC formed on untargeted PNPs (uPNPs) and targeted PNPs (tPNPs), paying particular attention to complement activation. | ||
| 650 | 4 | |a Complement system | |
| 650 | 4 | |a Human plasma | |
| 650 | 4 | |a Human serum | |
| 650 | 4 | |a Macrophages | |
| 650 | 4 | |a Mouse serum | |
| 650 | 4 | |a Polymeric nanoparticles | |
| 700 | 1 | |a Colombo, Federico |d 1988- |e VerfasserIn |0 (DE-588)1280334428 |0 (DE-627)1833427920 |4 aut | |
| 700 | 1 | |a Maso, Luca De |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mauro, Prisca |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bertoncin, Paolo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kähne, Thilo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Engler, Alexander |e VerfasserIn |4 aut | |
| 700 | 1 | |a Núñez, Luis |e VerfasserIn |4 aut | |
| 700 | 1 | |a Spretz, Ruben |e VerfasserIn |4 aut | |
| 700 | 1 | |a Larsen, Gustavo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bo, Michele Dal |e VerfasserIn |4 aut | |
| 700 | 1 | |a Toffoli, Giuseppe |e VerfasserIn |4 aut | |
| 700 | 1 | |a Macor, Paolo |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of nanobiotechnology |d London : Biomed Central, 2003 |g 21(2023), Artikel-ID 376 |h Online-Ressource |w (DE-627)362770328 |w (DE-600)2100022-0 |w (DE-576)10701548X |x 1477-3155 |7 nnas |a Surface antibody changes protein corona both in human and mouse serum but not final opsonization and elimination of targeted polymeric nanoparticles |
| 773 | 1 | 8 | |g volume:21 |g year:2023 |g elocationid:376 |g extent:20 |a Surface antibody changes protein corona both in human and mouse serum but not final opsonization and elimination of targeted polymeric nanoparticles |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1186/s12951-023-02134-4 |x Resolving-System |z kostenfrei |
| 951 | |a AR | ||
| 992 | |a 20240119 | ||
| 993 | |a Article | ||
| 994 | |a 2023 | ||
| 998 | |g 1280334428 |a Colombo, Federico |m 1280334428:Colombo, Federico |d 160000 |d 160200 |e 160000PC1280334428 |e 160200PC1280334428 |k 0/160000/ |k 1/160000/160200/ |p 2 | ||
| 999 | |a KXP-PPN1869503732 |e 4462620348 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"recId":"1869503732","note":["Gesehen am 19.01.2024"],"origin":[{"dateIssuedDisp":"14 October 2023","dateIssuedKey":"2023"}],"name":{"displayForm":["Sara Capolla, Federico Colombo, Luca De Maso, Prisca Mauro, Paolo Bertoncin, Thilo Kähne, Alexander Engler, Luis Núñez, Ruben Spretz, Gustavo Larsen, Michele Dal Bo, Giuseppe Toffoli and Paolo Macor"]},"id":{"eki":["1869503732"],"doi":["10.1186/s12951-023-02134-4"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Surface antibody changes protein corona both in human and mouse serum but not final opsonization and elimination of targeted polymeric nanoparticles","title_sort":"Surface antibody changes protein corona both in human and mouse serum but not final opsonization and elimination of targeted polymeric nanoparticles"}],"relHost":[{"pubHistory":["1.2003 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Journal of nanobiotechnology","title":"Journal of nanobiotechnology"}],"id":{"zdb":["2100022-0"],"issn":["1477-3155"],"eki":["362770328"]},"origin":[{"publisherPlace":"London","dateIssuedKey":"2003","publisher":"Biomed Central","dateIssuedDisp":"2003-"}],"part":{"text":"21(2023), Artikel-ID 376","year":"2023","volume":"21","extent":"20"},"note":["Gesehen am 04.01.2021"],"recId":"362770328","language":["eng"],"disp":"Surface antibody changes protein corona both in human and mouse serum but not final opsonization and elimination of targeted polymeric nanoparticlesJournal of nanobiotechnology"}],"physDesc":[{"noteIll":"Illustrationen","extent":"20 S."}],"person":[{"family":"Capolla","display":"Capolla, Sara","role":"aut","given":"Sara"},{"role":"aut","given":"Federico","family":"Colombo","display":"Colombo, Federico"},{"given":"Luca De","role":"aut","display":"Maso, Luca De","family":"Maso"},{"given":"Prisca","role":"aut","display":"Mauro, Prisca","family":"Mauro"},{"family":"Bertoncin","display":"Bertoncin, Paolo","role":"aut","given":"Paolo"},{"display":"Kähne, Thilo","family":"Kähne","given":"Thilo","role":"aut"},{"display":"Engler, Alexander","family":"Engler","given":"Alexander","role":"aut"},{"display":"Núñez, Luis","family":"Núñez","given":"Luis","role":"aut"},{"given":"Ruben","role":"aut","display":"Spretz, Ruben","family":"Spretz"},{"family":"Larsen","display":"Larsen, Gustavo","role":"aut","given":"Gustavo"},{"given":"Michele Dal","role":"aut","display":"Bo, Michele Dal","family":"Bo"},{"family":"Toffoli","display":"Toffoli, Giuseppe","role":"aut","given":"Giuseppe"},{"role":"aut","given":"Paolo","family":"Macor","display":"Macor, Paolo"}]} | ||
| SRT | |a CAPOLLASARSURFACEANT1420 | ||